Identification of Six N7-Methylguanosine-Related miRNA Signatures to Predict the Overall Survival and Immune Landscape of Triple-Negative Breast Cancer through In Silico Analysis

Figure 6

Assessment of the prognostic model. (a–c) ROC curves for 1-, 3-, and 5-year OS rate of nomogram and clinicopathological factors. (d–f) Nomogram calibration curves for 1-, 3-, and 5-year OS prediction.

(a)

(b)

(c)

(d)

(e)

(f)